Tilray Brands, Inc.
USD5.11
-0.27 (-5.02%)
CEO
Irwin David Simon
IPO Date
2018-07-19
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
CA
Open
$5.33
Prev. Close
$5.38
Day Low
$5.11
Day High
$5.35
52W Low
$3.50
52W High
$23.20
Market Cap
$0.61B
Volume
3.27M
| 12,438 |
| $8.99 |
| 8 Jan 2026 | Cohen Steven Michael | director | M-Exempt | Disposed | 12,438 | $0.00 |
| 4 Aug 2025 | SIMON IRWIN D | President and CEO | M-Exempt | Acquired | 706,216 | $0.58 |
| 4 Aug 2025 | SIMON IRWIN D | President and CEO | F-InKind | Disposed | 374,295 | $0.58 |
| 4 Aug 2025 | SIMON IRWIN D | President and CEO | M-Exempt | Disposed | 353,108 | $0.00 |
| 4 Aug 2025 | Merton Carl A | Chief Financial Officer | M-Exempt | Acquired | 93,928 | $0.58 |
| 4 Aug 2025 | Merton Carl A | Chief Financial Officer | F-InKind | Disposed | 49,782 | $0.58 |
| 4 Aug 2025 | Merton Carl A | Chief Financial Officer | M-Exempt | Disposed | 46,964 | $0.00 |
| 4 Aug 2025 | Gendel Mitchell | Global General Counsel | M-Exempt | Acquired | 93,928 | $0.58 |
| 9 May 2022 | Brian Mast | Brian Mast | Sale (Full) | $1,001 - $15,000 |
| 17 Mar 2021 | Brian Mast | Brian Mast | Sale (Partial) | $15,001 - $50,000 |
| 17 Mar 2021 | Brian Mast | Brian Mast | Purchase | $50,001 - $100,000 |
| 19 Feb 2021 | John A. Yarmuth | John A. Yarmuth | Purchase | $1,001 - $15,000 |
| 1 Dec 2020 | Brian Mast | Brian Mast | Purchase | $15,001 - $50,000 |
| 15 Nov 2020 | John A. Yarmuth | John A. Yarmuth | Purchase | $1,001 - $15,000 |